BUY BLUESTARCO

Cash Intraday: BUY BLUESTARCO@375.5-377 SL 371.5 TRG 388

BUY TORNTPHARM

Cash Intraday: BUY TORNTPHARM @ 1460-1465 SL 1445 TRG 1505

Buy ICICI Bank

Short Term Delivery Call : Buy ICICI Bank @  307-308, Sl 302,  Target 330

Buy Axis bank

Short Term Delivery Call : Buy Axis bank @  575-577, Sl 568,  Target 620

Buy SUNPHARMA INTRADAY CALL

INTRADAY CALL ( NSE CASH )  Buy SUNPHARMA @ 672.00 - 673.00 Stop-Loss @ 666.00  Tgt 686.00

BUY JETAIRWAYS

Call for Day Traders ( NSE Cash ) BUY JET AIRWAYS @ 385.25 - 384.25 Stop-Loss @ 379.90 Tgt 395.00

POSITIONAL CALL BUY TVS MOTER

POSITIONAL CALL: BUY (532343) TVS MOTER @ 33.50-33.90 STOP-LOSS @ 31.40 TARGET(1) 36.40  TARGET(2) 38.20 FOR 3-4 TRADING SESSIONS

INTRADAY CALL BUY PFC

INTRADAY CALL : BUY (532810) PFC @ 151.50 -152 STOP-LOSS @ 148.60 TARGET(1) 155.40  TARGET(2) 158.20

INTRADAY CALL SELL LNT

INTRADAY CALL : SELL (500511) LNT @ 1212 -1213 STOP-LOSS @ 1226 TARGET(1) 1195.50 TARGET(2) 1183.10

POSITIONAL CALL: BUY MANAPFIN

POSITIONAL CALL: BUY (531213) MANAPFIN @ 24 -24.60 STOP-LOSS @ 20.60 TARGET(1) 29.50  TARGET(2) 32.20 FOR 5-6 TRADING SESSIOS

INTRADAY CALL JAINIRRIG

INTRADAY CALL : BUY (500219) JAINIRRIG @ 78 -78.90 STOP-LOSS @ 75.60 TARGET(1) 81.50  TARGET(2) 83.20

Haria Exports touches the roof on plan of demerging its garment division

Haria Exports is currently locked at its upper circuit limit of Rs 4.92, up by 0.23 points or 4.90% from its previous closing of Rs 4.69 on the BSE.

The scrip opened at Rs 4.92 and has touched a high and low of Rs 4.92 and Rs 4.92 respectively. So far 1513 shares were traded on the counter.

The BSE group 'T' stock of face value Rs 10 has touched a 52 week high of Rs 7.36 on 12-Jul-2010 and a 52 week low of Rs 3.03 on 11-May-2011.

Last one week high and low of the scrip stood at Rs 4.92 and Rs 3.68 respectively. The current market cap of the company is Rs 2.82 crore.

The promoters holding in the company stood at 12.96% while Institutions and Non-Institutions held 0.02% and 87.02% respectively. 

Haria Exports is eyeing for approval for scheme of arrangement involving demerger of its garment division and merger of Best Plastex with the company. For the propose scheme of arrangement the company will hold a board meeting of its directors on June 14, 2011.

Haria Exports offers garments and note books in India and internationally. It manufactures and exports garments comprising men’s and ladies' cotton shirts, towels and napkins as well as cotton fabrics. The company also offers note books.

Glenmark Pharma surges on its arm getting USFDA approval for Mupirocin ointment

Glenmark Pharma is currently trading at Rs. 314.30, up by 5.70 points or 1.85% from its previous closing of Rs. 308.60 on the BSE.

The scrip opened at Rs. 311.00 and has touched a high and low of Rs. 316.70 and Rs. 309.00 respectively. So far 70,486 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 389.75 on 07-Dec-2010 and a 52 week low of Rs. 241.60 on 28-Feb-2011.

Last one week high and low of the scrip stood at Rs. 316.70 and Rs. 304.55 respectively. The current market cap of the company is Rs. 8474.65 crore.

The promoters holding in the company stood at 48.31% while Institutions and Non-Institutions held 37.37% and 14.31% respectively.

Glenmark Generics’ (GGL) United States (US) subsidiary -- Glenmark Generics Inc., (GGI) -- has been granted final approval for its Abbreviated New Drug Application (ANDA) from the United States Food and Drug Administration (USFDA) for Mupirocin ointment USP, 2%.

Mupirocin ointment is indicated for the topical treatment of impetigo due to: Staphylococcus aureus and Streptococcus pyogenes and is available in a 22 gram tube presentation. Mupirocin ointment garnered annual sales of $55 million and achieved a 9% increase in growth compared to the same period last year.

Glenmark’s current portfolio consists of 68 products authorized for distribution in the US marketplace and 39 ANDA’s pending approval with the US FDA. In addition to these internal filings, GGI continues to identify and explore external development partnerships to supplement and accelerate the growth of the existing pipeline and portfolio.

GGL is a subsidiary of Glenmark Pharmaceuticals and aims to be a global integrated Generic and API leader. GGL has an established presence in North America, EU and Argentina and maintains marketing front-ends in these countries.

On consolidated basis, the group’s net profit after tax for the year ended March 31, 2011 increased marginally by 38.30% at Rs 457.83 crore as compared to Rs 331.03 crore for the previous year. Total income for the year increased by 21.93% at 3089.59 crore as compared to Rs 2533.81 crore for the previous year.

Phoenix Mills ascends on getting an upgradation in its fundamental grade to 3 /5

Phoenix Mills is currently trading at Rs 194.25, up by 3.45 points or 1.81% from its previous closing of Rs 190.80 on the BSE.
The scrip opened at Rs 196.90 and has touched a high and low of Rs 197.75 and Rs 193.00 respectively. So far 4176 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 269.25 on 09-Sep-2010 and a 52 week low of Rs 160.00 on 14-Mar-2011.
Last one week high and low of the scrip stood at Rs 197.75 and Rs 183.20 respectively. The current market cap of the company is Rs 2810.73 crore.
The promoters holding in the company stood at 65.92% while Institutions and Non-Institutions held 27.44% and 6.64% respectively.
Rating agency, CRISIL Equities has upgraded Phoenix Mills CRISIL IER fundamental grade to 3/5 from 2/5. The grade indicates that the company’s fundamentals are good relative to other listed equity securities in India. The rating agency has also assigned a valuation grade of 4/5 to the company.
The rating agency has revised the company’s fundamental grade following consistently strong performance by its consumption centre High Street Phoenix (HSP) in Mumbai, encouraging pre-leasing activities in upcoming market city projects and the company`s strong balance sheet despite it being in an asset-heavy retailing business.
The assigned grade factors in strong cash flows from HSP, an established retail destination housing marquee tenants such as Zara, Diesel, Manchester United CafA, Hamleys, etc. with more than 1 million footfalls a month.
Phoenix Mills engaged in property development in India. Its activities include planning, execution, and marketing of projects, property rental and management, and maintenance and sale of the completed properties.

Gujarat NRE Coke rises on the bourses

Gujarat NRE Coke is currently trading at Rs. 50.80, up by 1.25 points or 2.52% from its previous closing of Rs. 49.55 on the BSE.

The scrip opened at Rs. 50.00 and has touched a high and low of Rs. 51.50 and Rs. 50.00 respectively. So far 1,76,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 72.00 on 05-Jan-2011 and a 52 week low of Rs. 41.00 on 25-Feb-2011.

Last one week high and low of the scrip stood at Rs. 51.50 and Rs. 48.80 respectively. The current market cap of the company is Rs. 2668.64 crore.

The promoters holding in the company stood at 47.50% while Institutions and Non-Institutions held 29.14% and 23.36% respectively.

Gujarat NRE Coke has launched an issue of $50 million direct, unsubordinated, unconditional and unsecured convertible bonds due to matured by 2016. However, issue is subject to an over allocation of $10 million worth bonds convertible into ordinary equity shares of the company quoted in Indian Rupees. First International Group and UBS AG are appointed as the Joint Book runners for the offering of the bonds.

The bonds are proposed to the listed on the Singapore Exchange Securities Trading and the equity shares of the company to be issued upon conversion of the bonds shall be listed on the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE).

Further, the issue of the bonds and issuance at the equity of the company upon conversion of the bonds was authorized by a resolution of the Board of Directors of the company at a meeting held on October 21, 2010 and by a special resolution of the shareholders passed by postal ballot the result of which was declared on December 13, 2010. Further the opening of the issue has been authorized by a resolution of the management committee of the Board of Directors of the Company passed at a meeting held on June 09, 2011.

MMTC rises on the bourses

MMTC is currently trading at Rs. 916.00, up by 4.85 points or 0.53% from its previous closing of Rs. 911.15 on the BSE.
The scrip opened at Rs. 918.00 and has touched a high and low of Rs. 918.00 and Rs. 912.00 respectively.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1935.00 on 29-Jul-2010 and a 52 week low of Rs. 867.80 on 25-Mar-2011.
Last one week high and low of the scrip stood at Rs. 928.90 and Rs. 901.10 respectively. The current market cap of the company is Rs. 91115.00 crore.
The promoters holding in the company stood at 99.33% while Institutions and Non-Institutions held 0.52% and 0.15% respectively.
MMTC, the country’s largest foreign trading company, is planning to take a major leap in the non-conventional energy sector, after its successful pilot project in Karnataka. The company will invest around Rs 240 crore in the next two years to set up new wind mill units across the country, as a part of diversification.
The company has already commenced its first 15-MW wind farm project in Gajendragad, Karnataka. For the last four years the state-owned firm owns 100 acres of wind farm with 54 wind mills generating over 102 million units of power. It supplies electricity to HESCOM/KPTCL, a unit of Hubli Electricity Supply Company of the Karnataka.
The company’s new investment plan comes in the wake of the success of its 15 MW windmill plant in Karnataka. The pilot project comprising of 25 windmill units was set up in Gajendragad in Gadag district with an investment of Rs 68.75 crore in 2007.

Ashok Leyland gains on its plans to be among top 10 truck-makers globally

Ashok Leyland is currently trading at Rs. 59.25, up by 0.85 points or 1.46% from its previous closing of Rs. 58.40 on the NSE.

The scrip opened at Rs. 59.00 and has touched a high and low of Rs. 59.80 and Rs. 58.70 respectively. So far 11,76,244 shares were traded on the counter.

The NSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 81.90 on 08-Nov-2010 and a 52 week low of Rs. 45.10 on 24-Feb-2011.

Last one week high and low of the scrip stood at Rs. 59.80 and Rs. 56.10 respectively. The current market cap of the company is Rs. 7849.00 crore.

The promoters holding in the company stood at 38.61% while Institutions and Non-Institutions held 31.33% and 16.62% respectively.

Ashok Leyland in a bid to break into the list of top 10 global truck manufacturers and top five bus makers in the next 5-10 years is adopting a three-pronged strategy. The company is currently among list of top 20 in truck manufacturing and among top 10 in bus manufacturing globally.

The three-prolonged strategies on which the company will be working would be - focusing on delivering quality products, developing and managing people, and leveraging the value of products by adopting new branding exercise.

Ashok Leyland had set a target of selling around 1.10 lakh to 1.20 lakh units during this financial year (2011-12). Till March 31, the company has sold 94,100 units with exports contributing over 10,000. The company has also ramped up the capacity of its Pant Nagar facility to produce 30,000-40,000 vehicles from next year from the present 2,600 units.

Recently, Ashok Leyland and Japanese auto-maker Nissan Motor Company rolled out their first light commercial vehicle under the brand, 'Ashok Leyland - DOST'. The company’s net profit for the quarter ended December 31, 2010 has plunged by 58.55% at Rs 43.37 crore as compared to Rs 104.63 crore for the quarter ended December 31, 2009.

Gravita India jumps on acquiring K. M. Udyog, Jammu

Gravita India is currently trading at Rs. 410.80, up by 8.70 points or 2.16% from its previous closing of Rs. 402.10 on the BSE.
The scrip opened at Rs. 406.05 and has touched a high and low of Rs. 412.90 and Rs. 406.05 respectively. So far 51,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 421.85 on 04-Apr-2011 and a 52 week low of Rs. 165.70 on 10-Dec-2010.
Last one week high and low of the scrip stood at Rs. 421.85 and Rs. 335.60 respectively. The current market cap of the company is Rs. 547.66 crore.
The promoters holding in the company stood at 73.52% while Institutions and Non-Institutions held 7.45% and 19.03% respectively.
Gravita India together with its subsidiary company - Gravita Exim has acquired 60% stake in K. M. Udyog, Jammu. The installed lead manufacturing and refining capacity of K. M. Udyog, Jammu is 7200 MT per annum.
With this acquisition, the enhanced capacity of the company will be 45,900 MT per annum. The addition of K. M. Udyog, Jammu is expected to improve the top and bottom line of Gravita India by around rupees sixty five crores and rupees three crores respectively during the financial year 2011-12.
In January this year, Gravita India’s subsidiary - Gravita Exim - has completed the disinvestment of 287,450,000 shares of ZMK 1 each, held by the said subsidiary in Gravita Zambia on December 25, 2010. Gravita Zambia, a wholly owned subsidiary of Gravita Group of Companies, is a growing name in Lead Recycling & Process industries of Zambia. The company is promoted to manufacture Remelted Lead & Plastic Recycling.
Gravita India manufactures lead metal using recycling and smelting process, besides it also makes other lead based products and lead alloys. Lead is the second most recycled metal in the world and is also most widely used across in industrial sectors, especially automobiles.

Supreme Infrastructure surges on revision in ratings assigned to the bank facilities of the company by CARE

Supreme Infrastructure is currently trading at Rs. 210.15, up by 1.20 points or 0.57% from its previous closing of Rs. 208.95 on the BSE.
The scrip opened at Rs. 207.55 and has touched a high and low of Rs. 216.50 and Rs. 207.55 respectively. So far 5200 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 319.80 on 20-Aug-2010 and a 52 week low of Rs. 175.00 on 01-Apr-2010.
Last one week high and low of the scrip stood at Rs. 216.50 and Rs. 195.25 respectively. The current market cap of the company is Rs. 359.95 crore.
The promoters holding in the company stood at 56.61% while Institutions and Non-Institutions held 12.23% and 31.16% respectively.
Credit rating agency, CARE has revised the ratings of Rs 224.75 crore long term bank facilities of Supreme Infrastructure to ‘BBB-‘from ‘BB+’. The rating agency has also revised the ratings of Rs 300 crore short term bank facilities of the company to PR3 from PR4.
The rating revision takes into account the improved financial performance of the company in terms of sales, profitability during FY10 and 9M FY11 and improved leverage position and average collection period in 9M FY11. The ratings continue to factor in the promoters’ long experience in execution of construction contracts, qualified management team, revenue visibility in the medium term, comfortable profitability margins and growth prospects of the infrastructure sector in general.
Supreme Infrastructure is engaged in the construction of highways, roads and bridges and engineering works. It also manufactures crushed metals, ready-mix concrete, asphalt and wet mix macadam.

Aurobindo Pharma gains on getting final approval from USFDA for Fosinopril Sodium

Aurobindo Pharma is currently trading at Rs 194.50, up by 0.70 points or 0.36% from its previous closing of Rs 193.80 on the BSE.
The scrip opened at Rs 198.40 and has touched a high and low of Rs 198.50 and Rs 192.75 respectively. So far 235783 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 1 has touched a 52 week high of Rs 275.00 on 05-Jan-2011 and a 52 week low of Rs 156.50 on 25-Feb-2011.
Last one week high and low of the scrip stood at Rs 203.95 and Rs 184.65 respectively. The current market cap of the company is Rs 5649.21 crore.
The promoters holding in the company stood at 54.40% while Institutions and Non-Institutions held 35.80% and 9.81% respectively. Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fosinopril Sodium Tablets USP 10mg, 20mg and 40mg.
Fosinopril Sodium Tablets USP 10mg, 20mg, and 40mg is the generic version of Bristol-Myers Squibb Company Pharmaceutical Research Institute’s Monopril tablets 10mg, 20mg, and 40mg. The product falls under the cardiovascular (CVS) therapeutic category and is indicated for the treatment of hypertension. The product has a market size of about $20 million for the twelve months ending September 2010.